Literature DB >> 10654496

Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function.

Y Saitoh1, M Hashimoto, K Ku, S Kin, S Nosaka, S Masumura, K Nakayama.   

Abstract

BACKGROUND: Poor myocardial tolerance to prolonged cold ischemia remains a major concern in heart transplantation. In this study, we estimated superiority of Histidine-Tryptophan-Ketoglutarate (HTK) over University of Wisconsin (UW) as a cardiac preservation solution.
METHODS: Isolated rat hearts were mounted on a Langendorff apparatus to estimate the baseline cardiac function. The hearts were arrested and stored at 4 degrees C in UW and HTK solution for 8 hours, and then reperfused. The aortic flow, coronary flow, cardiac output, rate pressure product, and left ventricular dp/dt in the HTK group recovered significantly more than the UW group. The values of myocardial total adenine nucleotides and the adenosine triphosphate to adenosine diphosphate ratio were higher in the HTK than in the UW group. We also examined coronary vascular responsiveness using left coronary arteries dissected from the rat hearts before flushing, before storage, after storage, and after reperfusion.
RESULTS: The maximal relaxation response to acetylcholine was significantly higher in the HTK than in the UW group after reperfusion, although there were no significant differences at each stage before reperfusion. In addition, the endothelium-independent relaxation response to sodium nitroprusside in the HTK group was also well preserved after reperfusion.
CONCLUSIONS: These results indicate that HTK is superior to UW solution for cardiac preservation. HTK protects coronary vasculature during preservation, which together with reperfusion might lead to improved functional cardiac recovery following preservation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654496     DOI: 10.1016/s0003-4975(99)01190-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Custodiol for myocardial protection and preservation: a systematic review.

Authors:  J James B Edelman; Michael Seco; Ben Dunne; Shannon J Matzelle; Michelle Murphy; Pragnesh Joshi; Tristan D Yan; Michael K Wilson; Paul G Bannon; Michael P Vallely; Jurgen Passage
Journal:  Ann Cardiothorac Surg       Date:  2013-11

2.  Changes of noradrenaline-induced contractility and gene expression in aorta of rats acclimated to heat in two different modes.

Authors:  Guang Hua Li; Masanori Katakura; Megumi Maruyama; Budbazar Enhkjargal; Kentaro Matsuzaki; Michio Hashimoto; Osamu Shido
Journal:  Eur J Appl Physiol       Date:  2008-05-30       Impact factor: 3.078

3.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

4.  Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 hours preserves function and metabolism.

Authors:  David F Stowe; Amadou K S Camara; James S Heisner; Mohammed Aldakkak; David R Harder
Journal:  J Heart Lung Transplant       Date:  2008-07-26       Impact factor: 10.247

5.  Perturbations in cardiac metabolism in a human model of acute myocardial ischaemia.

Authors:  Sanoj Chacko; Mamas A Mamas; Magdi El-Omar; David Simon; Sohaib Haseeb; Farzin Fath-Ordoubadi; Bernard Clarke; Ludwig Neyses; Warwick B Dunn
Journal:  Metabolomics       Date:  2021-08-23       Impact factor: 4.290

6.  Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.

Authors:  X W Li; Y Z Lin; H Lin; J B Huang; X M Tang; X M Long; W J Lu; Z K Wen; J Liang; D Y Li; X F Zhao
Journal:  Braz J Med Biol Res       Date:  2016-05-13       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.